Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Illumina, Inc.

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ILMN●NASDAQ
HealthcareMedical - Diagnostics & Research
$199.87
$3.14(1.55%)
U.S. Market opens in 11h 44m

Illumina, Inc. (ILMN)

Meyka AI Score

Z

Key Financials

Market Cap30.2B
P/E Ratio36.53
EPS (TTM)$5.03
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$180.33
3 Months$230.88
1 Year Target$128.23

ILMN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Illumina, Inc. (NASDAQ: ILMN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Illumina, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ILMN on the NASDAQ shows an RSI of 58.00, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $128.23 for the NASDAQ listing.

Key metrics behind Illumina, Inc.'s NASDAQ-traded stock include a P/E ratio of 36.53 and a market capitalization of 30.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ILMN on the NASDAQ.

Price Performance (NASDAQ: ILMN)

1-Day Change
-1.55%
5-Day Change
-1.68%
1-Month Change
2.85%
3-Month Change
43.72%
6-Month Change
49.59%
Year-to-Date (YTD) Change
52.39%
1-Year Change
104.45%
3-Year Change
9.85%
5-Year Change
-60.12%
All-Time (Max) Change
950.29%

Contact Information

https://www.illumina.com
858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

86,000 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions